Top Page
Icl
(NYSE:ICL)
Icl (ICL) vs. SPDR S&P 500 ETF (SPY)
Icl Business Overview & Revenue Model
Icl Earnings Call Summary
Icl Financial Statement Overview
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.15B | 6.84B | 7.54B | 10.02B | 6.96B |
| Gross Profit | 2.19B | 2.26B | 2.67B | 5.03B | 2.61B |
| EBITDA | 1.32B | 1.38B | 1.67B | 4.04B | 1.72B |
| Net Income | 226.00M | 407.00M | 647.00M | 2.16B | 783.00M |
Balance Sheet | |||||
| Total Assets | 12.41B | 11.32B | 11.63B | 11.75B | 11.08B |
| Cash, Cash Equivalents and Short-Term Investments | 496.00M | 442.00M | 592.00M | 508.00M | 564.00M |
| Total Debt | 2.76B | 2.29B | 2.69B | 2.82B | 3.01B |
| Total Liabilities | 6.17B | 5.33B | 5.59B | 6.04B | 6.34B |
| Stockholders Equity | 5.98B | 5.72B | 5.77B | 5.46B | 4.53B |
Cash Flow | |||||
| Free Cash Flow | 130.00M | 650.00M | 815.00M | 1.38B | 454.00M |
| Operating Cash Flow | 954.00M | 1.36B | 1.59B | 2.13B | 1.06B |
| Investing Cash Flow | -930.00M | -711.00M | -863.00M | -747.00M | -579.00M |
| Financing Cash Flow | -78.00M | -724.00M | -712.00M | -1.42B | -244.00M |
Icl Technical Analysis
Icl Risk Analysis
Icl Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $15.30B | 11.10 | 29.62% | 2.56% | 12.59% | 31.40% | |
68 Neutral | $1.05B | 10.67 | 35.31% | 12.33% | 16.52% | 141.96% | |
64 Neutral | $8.84B | 16.42 | 4.61% | 3.70% | 3.82% | 239.39% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | $6.70B | 29.64 | 3.86% | 3.36% | 1.77% | -8.72% | |
58 Neutral | $496.39M | -2.44 | -33.37% | ― | 8.88% | -349.99% | |
49 Neutral | $1.84B | -0.83 | -66.80% | 16.68% | -13.42% | -136.59% |
Icl Corporate Events
On February 18, 2026, ICL reported that fourth-quarter 2025 sales rose 6% year on year to $1.7 billion, with adjusted EBITDA up 10% to $380 million, even as reported operating income swung to a loss due to $239 million in unusual charges tied to strategic changes and a water-fee provision. These charges reflected the discontinuation of LFP battery materials projects in St. Louis and Spain, R&D efficiency moves in Israel, and an impairment at its U.K. assets.
For full-year 2025, sales grew 5% to $7.15 billion and adjusted EBITDA edged up to $1.49 billion, while reported earnings declined on the back of the extraordinary items and net income fell to $226 million. The company advanced a portfolio shift by acquiring Bartek Ingredients, initiating a review and possible divestment of its Boulby operations in the U.K., and sharpening capital allocation toward its specialty crop nutrition and specialty food solutions growth engines, while guiding 2026 adjusted EBITDA to a range of $1.4 billion to $1.6 billion and maintaining potash volumes of 4.5 to 4.7 million tons.
The most recent analyst rating on (ICL) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Icl stock, see the ICL Stock Forecast page.
On February 17, 2026, ICL Group Ltd.’s board of directors approved a cash dividend of $0.04650 per share, totaling about $60 million, with some shareholders to receive payment in New Israeli Shekels based on the Bank of Israel’s representative exchange rate on March 9, 2026. The dividend, which is subject to minimum entitlement of $2 per shareholder, carries a record date of March 10, 2026 and a payment date of March 25, 2026, and will be subject to differentiated Israeli withholding tax rates for resident and foreign investors, underscoring the company’s ongoing capital return policy and its implications for both local and international shareholders.
The most recent analyst rating on (ICL) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Icl stock, see the ICL Stock Forecast page.
On February 18, 2026, ICL Group filed a Form 6-K with the U.S. SEC, furnishing its fourth-quarter 2025 investor presentation and incorporating this report by reference into its existing Form S-8 registration statement and its Israeli shelf prospectus dated September 19, 2025. The filing, signed by the CFO and chief compliance officer, highlights a strategic focus on optimization and efficiency, including maximizing potash and phosphate output under a newly signed concession agreement, maintaining bromine market leadership, discontinuing an LFP project, initiating the sale of the Boulby operation and adjusting its cost structure alongside growth moves such as acquiring Lavie Bio, with implications for portfolio streamlining and capital allocation priorities.
The most recent analyst rating on (ICL) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Icl stock, see the ICL Stock Forecast page.
On January 27, 2026, ICL Group and its Dead Sea subsidiaries signed a detailed and binding agreement with the State of Israel governing the transfer and valuation of the assets used under the Dead Sea concession, which is scheduled to expire on March 31, 2030. The accord implements principles from a November 5, 2025 memorandum of understanding and sets out that all fixed and certain intangible assets required for the concession’s operation will be transferred in fit and operational condition to the state or to the future concession holder at the end of the current term, with pre‑expiry third‑party claims remaining with ICL’s Dead Sea companies and post‑expiry claims shifting to the state or the new operator. In return, the state will pay ICL a total of $2.54 billion plus reimbursement of qualifying salt-harvesting investments made from January 1, 2025, subject to a new investment and maintenance regime that obliges the Dead Sea companies to maintain multi‑year and annual minimum spending levels, with upward or downward adjustments to the consideration based on actual investment. The payment structure provides for 95% of the adjusted consideration to be paid on April 1, 2030 and the remaining 5% on September 1, 2030, with further reimbursement tied to completion of the permanent salt-harvesting solution. ICL says the agreement removes significant uncertainty around the 2030 concession expiry and the future competitive tender, clarifies the mechanism and timing of asset compensation, and should not have a material impact on its financial results, while positioning the company to plan its operations and potentially bid for the future concession if the terms prove economically and regulatorily attractive.
The most recent analyst rating on (ICL) stock is a Hold with a $6.15 price target. To see the full list of analyst forecasts on Icl stock, see the ICL Stock Forecast page.
On December 23, 2025, ICL Group Ltd. reported that, under its 2025–2027 framework arrangements with Chinese customers, it has signed contracts to deliver 750,000 metric tons of potash to China during 2026, with a mutual option for an additional 330,000 metric tons, priced in line with recent Chinese contract settlements at $348 per ton CIFFO. The new agreements reinforce ICL’s long-term sales visibility in one of its core fertilizer markets and underscore the company’s ongoing role as a key supplier to China’s agricultural sector within its existing multi‑year commercial framework.
The most recent analyst rating on (ICL) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Icl stock, see the ICL Stock Forecast page.
On a Form 6-K for December 2025, ICL Group Ltd. furnished an investor presentation to provide all shareholders equal access to materials it plans to use in upcoming investor meetings. The presentation, accompanied by extensive legal and forward-looking disclaimers, underscores ICL’s strategic emphasis on profitable growth engines in specialty crop nutrition and functional food ingredients, highlighting market estimates that point to mid‑single‑digit compound annual growth and more than 40% growth potential in specialty crop nutrition. It also details the company’s strong geographic presence, particularly in North America, Latin America (mainly Brazil), Europe and Asia-Pacific, reinforcing ICL’s view that it is well positioned to capture a significant share of a $35 billion addressable market in functional ingredients, an area seen as important for its long‑term growth and competitive positioning.
The most recent analyst rating on (ICL) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Icl stock, see the ICL Stock Forecast page.
On December 3, 2025, ICL Group Ltd. announced the publication of a draft bill of law for public comments concerning the future concession of the Dead Sea. This draft bill outlines proposed terms for the future concession, including regulatory provisions, revenue structures, and environmental regulations. The draft bill is part of the legislative process and aims to ensure maximum benefit for the State of Israel and the public. The company is currently reviewing the draft and will provide comments within the specified timeframe. The final implications of the draft bill on ICL Group’s operations remain uncertain as it is still in the initial stages of the legislative process.
The most recent analyst rating on (ICL) stock is a Hold with a $5.80 price target. To see the full list of analyst forecasts on Icl stock, see the ICL Stock Forecast page.
On December 3, 2025, ICL Group Ltd. announced that the Israeli Supreme Court ruled in favor of petitions requiring the company to pay water fees for water extraction in the Dead Sea Concession area, effective retroactively from January 1, 2018. This decision overturns a previous exemption based on the Israeli Ministry of Justice’s legal opinion. As a result, ICL estimates it will incur costs between $70-90 million for the period up to September 2025, with additional annual costs of $10-12 million expected until the concession’s expiration in 2030. The ruling could significantly impact ICL’s financial results for the fourth quarter of 2025 and alter its cost structure moving forward.
The most recent analyst rating on (ICL) stock is a Hold with a $5.80 price target. To see the full list of analyst forecasts on Icl stock, see the ICL Stock Forecast page.
ICL Group Ltd. announced a dividend distribution of approximately $62 million, with a dividend per share of $0.04800 for US dollar payments and ILS 0.1566720 for payments in Shekels. The record date for shareholders is December 2, 2025, with the payment scheduled for December 17, 2025. The announcement outlines the withholding tax rates applicable to Israeli and foreign residents, which vary depending on the shareholder’s residency and applicable international tax treaties. This distribution reflects ICL’s ongoing commitment to returning value to its shareholders.
The most recent analyst rating on (ICL) stock is a Hold with a $5.80 price target. To see the full list of analyst forecasts on Icl stock, see the ICL Stock Forecast page.